Pfizer Inc.
PFE
$27.05
$0.291.08%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/28/2026 | 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.73% | -41.89% | -39.47% | 62.72% | 402.20% |
| Total Depreciation and Amortization | 27.00% | -28.33% | -29.48% | -26.37% | -22.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 406.38% | 268.03% | 264.08% | 130.57% | -74.77% |
| Change in Net Operating Assets | -205.73% | 89.21% | 88.10% | -60.50% | 396.32% |
| Cash from Operations | -15.02% | -10.17% | -3.59% | 21.27% | 97.00% |
| Capital Expenditure | -13.32% | 32.00% | 30.87% | 31.39% | 33.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 111.94% | -85.37% | -34.62% | -96.72% | -95.97% |
| Cash from Investing | -1,300.25% | -285.77% | -299.92% | 88.41% | 89.25% |
| Total Debt Issued | 107.09% | -19.72% | -32.74% | -95.38% | -78.83% |
| Total Debt Repaid | 59.09% | 79.66% | 66.80% | 53.00% | -8.32% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -35.96% | 23.42% | 22.98% | 23.14% | 23.28% |
| Other Financing Activities | -4.52% | 16.40% | 6.40% | 13.53% | 25.40% |
| Cash from Financing | 43.91% | 72.83% | 58.53% | -94.68% | -161.52% |
| Foreign Exchange rate Adjustments | 181.48% | 157.78% | 100.00% | 10.53% | 65.82% |
| Miscellaneous Cash Flow Adjustments | 200.00% | 300.00% | -- | -- | -166.67% |
| Net Change in Cash | -284.36% | -90.58% | 93.20% | 101.39% | 122.74% |